As of September 29, 2026, Corvus Pharmaceuticals's top three insider holders are Advisors Llc Orbimed (Director, 7.17Mn shares), Peter A. Thompson (Director, 7.17Mn shares), Richard A Md Miller (President And Ceo, 1.20Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Advisors Llc Orbimed | Director, TenPercentOwner | 0 | 7,165,006 | 7,165,006 | 79.7% | 01 Jul, 2025 |
| 2 | Richard A Md Miller | President And Ceo | 0 | 1,195,035 | 1,195,035 | 13.3% | 20 May, 2026 |
| 3 | Peter A. Thompson | Director, TenPercentOwner | 210,000 | 0 | 210,000 | 2.3% | 30 Jan, 2026 |
| 4 | William Benton Jones | Officer | 173,130 | 0 | 173,130 | 1.9% | 06 Jun, 2025 |
| 5 | Leiv Lea | Chief Financial Officer | 0 | 133,238 | 133,238 | 1.5% | 15 Dec, 2022 |
| 6 | Capital, Llc Ecor1 | TenPercentOwner | 0 | 81,077 | 81,077 | 0.9% | 01 Oct, 2021 |
| 7 | David Scott Moore | Director | 21,700 | 0 | 21,700 | 0.2% | 15 Jun, 2026 |
| 8 | Linda Grais | Director | 10,000 | 0 | 10,000 | 0.1% | 16 May, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Jun, 2026 | Linda Grais | Director | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 11 Jun, 2026 | David Scott Moore | Director | Acquired P | 21,700 | $11.53 | $250.24K | 21,700 | Direct |
| 11 Jun, 2026 | Den Broek Richard Van | Director | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 11 Jun, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 11 Jun, 2026 | Ian T Clark | Director | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 11 Jun, 2026 | David Scott Moore | Director | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 18 May, 2026 | Richard A Md Miller | President And Ceo | Acquired P | 5,000 | $12.05 | $60.25K | 1,193,103 | Indirect |
| 18 May, 2026 | Richard A Md Miller | President And Ceo | Acquired P | 1,932 | $12.01 | $23.20K | 1,195,035 | Indirect |
| 23 Apr, 2026 | Andrew C. Chan | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 30,000 | $15.00 | $450.00K | 30,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $9.70 | $145.50K | 45,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $12.50 | $187.50K | 60,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $3.61 | $54.15K | 75,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $2.00 | $30.00K | 90,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $3.27 | $49.05K | 105,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $2.74 | $41.10K | 120,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $2.60 | $39.00K | 135,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $0.99 | $14.85K | 150,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $0.97 | $14.48K | 165,000 | Direct |
| 28 Jan, 2026 | Peter A. Thompson | Director, TenPercentOwner | Acquired M | 15,000 | $2.49 | $37.35K | 180,000 | Direct |